药品注册申请号:017681
申请类型:NDA (新药申请)
申请人:ESJAY PHARMA
申请人全名:ESJAY PHARMA LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 HIPREX METHENAMINE HIPPURATE TABLET;ORAL 1GM Yes No AB 1976/09/09 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2021/12/28 SUPPL-19(补充) Approval Manufacturing (CMC) N/A
2017/12/01 SUPPL-18(补充) Approval Labeling STANDARD Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.
2016/08/01 SUPPL-15(补充) Approval Manufacturing (CMC) STANDARD
2005/11/21 SUPPL-14(补充) Approval Labeling STANDARD
2004/06/10 SUPPL-13(补充) Approval Labeling STANDARD
1989/01/03 SUPPL-9(补充) Approval Manufacturing (CMC) STANDARD
1988/08/09 SUPPL-11(补充) Approval Manufacturing (CMC) STANDARD
1988/04/28 SUPPL-10(补充) Approval Manufacturing (CMC) STANDARD
1984/05/03 SUPPL-8(补充) Approval Manufacturing (CMC) STANDARD
1984/04/25 SUPPL-7(补充) Approval Manufacturing (CMC) STANDARD
1982/05/26 SUPPL-6(补充) Approval Manufacturing (CMC) STANDARD
1981/03/19 SUPPL-5(补充) Approval Labeling
1980/11/25 SUPPL-4(补充) Approval Labeling
1980/11/25 SUPPL-3(补充) Approval Labeling
1978/02/27 SUPPL-2(补充) Approval Manufacturing (CMC) STANDARD
1978/02/24 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
1976/09/09 ORIG-1(原始申请) Approval Type 5 - New Formulation or New Manufacturer STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:METHENAMINE HIPPURATE 剂型/给药途径:TABLET;ORAL 规格:1GM 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
016151 001 NDA UREX METHENAMINE HIPPURATE TABLET;ORAL 1GM Prescription No No AB Approved Prior to Jan 1, 1982 ALVOGEN
017681 001 NDA HIPREX METHENAMINE HIPPURATE TABLET;ORAL 1GM Prescription Yes No AB Approved Prior to Jan 1, 1982 ESJAY PHARMA
205661 001 ANDA METHENAMINE HIPPURATE METHENAMINE HIPPURATE TABLET;ORAL 1GM Prescription No Yes AB 2016/07/05 AUROBINDO PHARMA LTD
212172 001 ANDA METHENAMINE HIPPURATE METHENAMINE HIPPURATE TABLET;ORAL 1GM Prescription No No AB 2019/08/01 MICRO LABS
210068 001 ANDA METHENAMINE HIPPURATE METHENAMINE HIPPURATE TABLET;ORAL 1GM Prescription No No AB 2020/11/27 NOVAST LABS
217675 001 ANDA METHENAMINE HIPPURATE METHENAMINE HIPPURATE TABLET;ORAL 1GM Prescription No No AB 2023/12/01 JUBILANT CADISTA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database